- NRXP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
NRx Pharmaceuticals (NRXP) S-1IPO registration
Filed: 3 Sep 21, 5:21pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated May 11, 2021, with respect to the consolidated financial statements of NRx Pharmaceuticals, Inc., included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Short Hills, New Jersey
September 3, 2021
KPMG LLP, a Delaware limited liability partnership and a member firm of
the KPMG global organization of independent member firms affiliated with
KPMG International Limited, a private English company limited by guarantee.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.